anmelden
SMI Equal Weight
372,28
PKT
-0,21
PKT
-0,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Equal Weight-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.02.05 | UBS Übergewichten | Reuschel & Co | |
| 17.02.05 | Lonza Reduce | Sarasin Research | |
| 18.02.05 | Holcim Accumulate | Helvea | |
| 17.02.05 | Roche Hold | Crédit Suisse | |
| 18.02.05 | Lonza Buy | Helvea | |
| 17.02.05 | Richemont Verkaufen | Helaba Trust | |
| 16.02.05 | Holcim Halten | Helaba Trust | |
| 16.02.05 | Lonza Buy | Helvea | |
| 16.02.05 | UBS Kaufen | Hamburger Sparkasse | |
| 14.02.05 | Holcim Verkaufen | Helaba Trust | |
| 14.02.05 | Nestlé Neutral | Sarasin Research | |
| 15.02.05 | UBS Neutral | Merrill Lynch | |
| 15.02.05 | Swisscom Neutral | Credit Suisse First Boston | |
| 11.02.05 | Zurich Insurance Neutral | JP Morgan | |
| 14.02.05 | UBS Halten | Helaba Trust | |
| 11.02.05 | Zurich Insurance Outperform | Goldman Sachs | |
| 14.02.05 | UBS Buy | Sarasin Research | |
| 21.02.05 | Roche Marketperformer | Sparkasse KölnBonn | |
| 11.02.05 | Nestlé Neutral | Sarasin Research | |
| 10.02.05 | Zurich Insurance Buy | Merrill Lynch | |
| 10.02.05 | UBS Buy | Sarasin Research | |
| 11.02.05 | Swiss Life Akkumulieren | Nord LB | |
| 10.02.05 | Swiss Life Buy | Merck Finck & Co | |
| 10.02.05 | Swiss Life Outperform | HypoVereinsbank | |
| 10.02.05 | Swiss Life Buy | M.M. Warburg | |
| 10.02.05 | Swiss Life Marketperformer | LB Rheinland-Pfalz | |
| 10.02.05 | Swiss Life Outperform | HypoVereinsbank | |
| 09.02.05 | Roche Buy | Merrill Lynch | |
| 10.02.05 | Zurich Insurance Halten | Helaba Trust | |
| 11.02.05 | UBS Outperformer | Sparkasse KölnBonn | |
| 09.02.05 | Swiss Life Buy | Merck Finck & Co | |
| 09.02.05 | UBS Overweight | JP Morgan | |
| 09.02.05 | Logitech Neutral | Sarasin Research | |
| 09.02.05 | UBS Buy | Sarasin Research | |
| 09.02.05 | Novartis Buy | Merrill Lynch | |
| 09.02.05 | UBS Outperform | Goldman Sachs | |
| 08.02.05 | ABB (Asea Brown Boveri) Neutral | JP Morgan | |
| 08.02.05 | UBS Akkumulieren | Independent Research | |
| 09.02.05 | Richemont Buy | Sarasin Research | |
| 08.02.05 | UBS Outperform | Credit Suisse First Boston |